-
Comparing web-based platforms for promoting HIV self-testing and PrEP uptake in high-risk MSM: Protocol for a longitudinal cohort study.
Lemley SM, Klausner JD, Young SD, Stafylis C, Mulatya C, Oden NL, Xie H, Revoredo L, Blumberg D, Hichborn E, McKelle E, Moran L, Jacobs P, Marsch LA. Comparing web-based platforms for promoting HIV self-testing and PrEP uptake in high-risk MSM: Protocol for a longitudinal cohort study. JMIR Research Protocols 2020;9(10):e20417.
-
Increased morbidity and mortality in hypertensive patients with substance use disorders: Electronic health record findings.
Winhusen TJ, Theobald J, Kaelber DC, Lewis DF. Increased morbidity and mortality in hypertensive patients with substance use disorders: Electronic health record findings. Journal of Studies on Alcohol and Drugs 2020;81(4):471-478.
-
Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians.
Randesi M, Rotrosen J, Nunes EV, Lee JD, Novo P, Levran O, Ott J, Pavlicova M, Scodes J, Kreek MJ. Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians. American Journal of Drug and Alcohol Abuse 2020;46(6):761-768.
-
Dental care utilization of hospitalized persons living with HIV and substance use.
Santella AJ, Parish C, Dan R, Feaster DJ, Rodriguez AE, del Rio C, Armstrong WS, Jacobs P, Metsch LR. Dental care utilization of hospitalized persons living with HIV and substance use. Journal of Community Health 2020;46:557-564.
-
Measurement nonequivalence of the Clinician-Administered PTSD Scale by race/ethnicity: Implications for quantifying posttraumatic stress disorder severity.
Ruglass LM, Morgan-Lopez AA, Saavedra LM, Hien DA, Fitzpatrick S, Killeen TK, Back SE, Lopez-Castro T. Measurement nonequivalence of the Clinician-Administered PTSD Scale by race/ethnicity: Implications for quantifying posttraumatic stress disorder severity. Psychological Assessment 2020;32(11):1015-1027.
-
The relationship between housing status and substance use and sexual risk behaviors among people currently seeking or receiving services in substance use disorder treatment programs.
Pan Y, Metsch LR, Wang W, Philbin M, Kyle TL, Gooden LK, Feaster DJ. The relationship between housing status and substance use and sexual risk behaviors among people currently seeking or receiving services in substance use disorder treatment programs. Journal of Primary Prevention 2020;41:363-382.
-
Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic [editorial].
Cochran G, Bruneau J, Cox N, Gordon AJ. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic [editorial]. Substance Abuse 2020;41(3):269-274.
-
Cannabis use, other drug use, and risk of subsequent acute care in primary care patients.
Matson TE, Lapham GT, Bobb JF, Johnson E, Richards JE, Lee AK, Bradley KA, Glass JE. Cannabis use, other drug use, and risk of subsequent acute care in primary care patients. Drug and Alcohol Dependence 2020;216:108227.
-
Sexual risk Among African Americans in substance use treatment: Secondary analysis of two clinical trials.
McCuistian C, Peteet BJ, Burlew AK, Miller-Roenigk BD, Lige Q, Campbell ANC, Tross S. Sexual risk Among African Americans in substance use treatment: Secondary analysis of two clinical trials. Sexuality & Culture 2020;24:2065-2078.
-
Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trial.
Jalali A, Ryan DA, Jeng PJ, McCollister KE, Leff JA, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR, Murphy SM. Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trial. Drug and Alcohol Dependence 2020;215:108221